Verdict Food Service
- Home
- CVRX
CVRX
CVRx Inc.
as of 11-28-2025 12:24pm EST
$9.77
$0.06
-0.66%
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Chart Type:
Time Range:
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | MINNEAPOLIS |
| Market Cap: | 253.2M | IPO Year: | 2021 |
| Target Price: | $13.17 | AVG Volume (30 days): | 275.1K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.30 - $18.55 | Next Earning Date: | 11-05-2025 |
| Revenue: | $55,969,000 | Revenue Growth: | 18.44% |
| Revenue Growth (this year): | 11.32% | Revenue Growth (next year): | 18.58% |
AI-Powered CVRX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 79.02%
79.02%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of CVRx Inc. (CVRX)
JOHNSON & JOHNSON
Sell
10% Owner
CVRX Nov 24, 2025
Avg Cost/Share
$10.06
Shares
4,400
Total Value
$44,264.00
Owned After
4,047,198
JOHNSON & JOHNSON
Sell
10% Owner
CVRX Nov 21, 2025
Avg Cost/Share
$10.00
Shares
1,000
Total Value
$10,000.00
Owned After
4,047,198
JOHNSON & JOHNSON
Sell
10% Owner
CVRX Nov 12, 2025
Avg Cost/Share
$10.00
Shares
2,000
Total Value
$20,000.00
Owned After
4,047,198
JOHNSON & JOHNSON
Sell
10% Owner
CVRX Nov 7, 2025
Avg Cost/Share
$10.00
Shares
400
Total Value
$4,000.00
Owned After
4,047,198
JOHNSON & JOHNSON
Sell
10% Owner
CVRX Nov 6, 2025
Avg Cost/Share
$10.21
Shares
104,664
Total Value
$1,068,619.44
Owned After
4,047,198
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | CVRX | 10% Owner | Nov 24, 2025 | Sell | $10.06 | 4,400 | $44,264.00 | 4,047,198 | |
| JOHNSON & JOHNSON | CVRX | 10% Owner | Nov 21, 2025 | Sell | $10.00 | 1,000 | $10,000.00 | 4,047,198 | |
| JOHNSON & JOHNSON | CVRX | 10% Owner | Nov 12, 2025 | Sell | $10.00 | 2,000 | $20,000.00 | 4,047,198 | |
| JOHNSON & JOHNSON | CVRX | 10% Owner | Nov 7, 2025 | Sell | $10.00 | 400 | $4,000.00 | 4,047,198 | |
| JOHNSON & JOHNSON | CVRX | 10% Owner | Nov 6, 2025 | Sell | $10.21 | 104,664 | $1,068,619.44 | 4,047,198 |
Latest CVRx Inc. News
CVRX Breaking Stock News: Dive into CVRX Ticker-Specific Updates for Smart Investing
PR Newswire
DAR GLOBAL RINGS THE LONDON STOCK EXCHANGE OPENING BELL AS SAUDI ARABIA REAL ESTATE OPENS TO THE WORLD
📈
AI Sentiment
Highly Positive
8/10
Retail Insight Network
Walmart opens first branded store in South Africa at Roodepoort
📈
AI Sentiment
Highly Positive
8/10
Investing.com
Tesla stock is a ’must own’ as world nears dramatic shift, Melius says
📈
AI Sentiment
Highly Positive
9/10
Compare CVRX vs Leading Stocks
See how CVRX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CVRX CVRx Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.